| Primary |
| Glaucoma |
35.8% |
| Product Used For Unknown Indication |
16.2% |
| Drug Use For Unknown Indication |
15.2% |
| Intraocular Pressure Increased |
7.4% |
| Hypertension |
5.5% |
| Supplementation Therapy |
2.4% |
| Dry Eye |
2.0% |
| Blood Cholesterol Increased |
1.7% |
| Hypothyroidism |
1.7% |
| Dry Eyes |
1.3% |
| Increased Intraocular Pressure |
1.3% |
| Intraocular Pressure |
1.3% |
| Diabetes Mellitus |
1.2% |
| Open Angle Glaucoma |
1.2% |
| Postoperative Care |
1.2% |
| Diabetes |
1.1% |
| Arthritis |
0.9% |
| Blood Pressure |
0.9% |
| Ocular Hypertension |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Ocular Hyperaemia |
24.2% |
| Vision Blurred |
12.1% |
| Scleral Hyperaemia |
7.7% |
| Inappropriate Schedule Of Drug Administration |
6.6% |
| Eye Irritation |
4.9% |
| Intraocular Pressure Increased |
4.9% |
| Drug Ineffective |
4.4% |
| Somnolence |
4.4% |
| Dry Mouth |
3.3% |
| Therapeutic Response Decreased |
3.3% |
| Visual Impairment |
3.3% |
| Eye Pain |
2.7% |
| Lacrimation Increased |
2.7% |
| Visual Acuity Reduced |
2.7% |
| Eye Pruritus |
2.2% |
| Headache |
2.2% |
| Nausea |
2.2% |
| Photophobia |
2.2% |
| Syncope |
2.2% |
| Anaphylactic Reaction |
1.6% |
|
| Secondary |
| Glaucoma |
46.0% |
| Drug Use For Unknown Indication |
10.3% |
| Product Used For Unknown Indication |
8.3% |
| Intraocular Pressure Increased |
5.6% |
| Supplementation Therapy |
5.2% |
| Hypertension |
4.8% |
| Open Angle Glaucoma |
3.2% |
| Intraocular Pressure |
2.4% |
| Hypothyroidism |
2.0% |
| Blood Cholesterol Increased |
1.6% |
| Dry Eye |
1.6% |
| Increased Intraocular Pressure |
1.6% |
| Postoperative Care |
1.6% |
| Dry Eyes |
1.2% |
| Blood Pressure Increased |
0.8% |
| Breast Lump Removal |
0.8% |
| Diabetes |
0.8% |
| Eye Infection Bacterial |
0.8% |
| Intraocular Pressure Test |
0.8% |
| Intraocular Pressure Test Abnormal |
0.8% |
|
| Ocular Hyperaemia |
12.9% |
| Intraocular Pressure Increased |
11.3% |
| Vision Blurred |
11.3% |
| Lacrimation Increased |
6.5% |
| Eye Irritation |
4.8% |
| Medication Error |
4.8% |
| Swelling Face |
4.8% |
| Visual Acuity Reduced |
4.8% |
| Visual Field Defect |
4.8% |
| Death |
3.2% |
| Dry Mouth |
3.2% |
| Headache |
3.2% |
| Inappropriate Schedule Of Drug Administration |
3.2% |
| Myopia |
3.2% |
| Psychotic Disorder |
3.2% |
| Skin Discolouration |
3.2% |
| Somnolence |
3.2% |
| Sudden Visual Loss |
3.2% |
| Therapeutic Response Decreased |
3.2% |
| Asthenia |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.3% |
| Glaucoma |
21.6% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
4.5% |
| Osteoporosis |
3.7% |
| Muscle Spasms |
2.9% |
| Cardiac Disorder |
2.5% |
| Diabetes Mellitus |
2.5% |
| Pulmonary Arterial Hypertension |
2.5% |
| Asthma |
2.3% |
| Eye Disorder |
2.1% |
| Lung Disorder |
2.1% |
| Open Angle Glaucoma |
2.1% |
| Toothache |
2.1% |
| Blood Cholesterol Increased |
1.9% |
| Multiple Sclerosis |
1.9% |
| Pain |
1.9% |
| Blood Cholesterol Abnormal |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Depression |
1.4% |
|
| Weight Decreased |
12.6% |
| Vomiting |
11.7% |
| Visual Impairment |
9.7% |
| Pneumonia |
7.8% |
| Ocular Hyperaemia |
6.8% |
| Death |
4.9% |
| Eye Irritation |
4.9% |
| Urinary Tract Infection |
4.9% |
| Stress Fracture |
3.9% |
| Visual Acuity Reduced |
3.9% |
| Bladder Disorder |
2.9% |
| Dyspnoea |
2.9% |
| Eye Pain |
2.9% |
| Fatigue |
2.9% |
| Insomnia |
2.9% |
| Intraocular Pressure Increased |
2.9% |
| Pain In Extremity |
2.9% |
| Partial Seizures |
2.9% |
| Rash |
2.9% |
| Retinal Vein Thrombosis |
2.9% |
|
